$1.97
+0.16 (+8.84%)
Open$1.84
Previous Close$1.81
Day High$1.99
Day Low$1.84
52W High$7.92
52W Low$1.22
Volume—
Avg Volume206.1K
Market Cap27.00M
P/E Ratio—
EPS$-1.89
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+1,281.7% upside
Current
$1.97
$1.97
Target
$27.22
$27.22
$16.99
$27.22 avg
$37.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 190.9K | 117.1K | 4.38M |
| Net Income | -28,075,330 | -15,498,863 | -1,275,702 |
| Profit Margin | -14,755.4% | -14,017.6% | -29.1% |
| EBITDA | -33,993,462 | -19,808,494 | -1,970,058 |
| Free Cash Flow | — | — | -1,043,157 |
| Rev Growth | +63.0% | +63.0% | +7.3% |
| Debt/Equity | — | — | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |